Evidence map›Paper›PMID 36339024›Full record

ArticleIUCrData2020

Ethyl 3,4-bis-(acet-yloxy)-2-(4-meth-oxy-phen-yl)pyrrol-idine-1-carboxyl-ate.

Sofia Dallasta Pedroso, Ignez Caracelli, Julio Zukerman-Schpector, Monica Soto-Monsalve, Regina H De Almeida Santos, Carlos Roque D Correia, Ariel L Llanes Garcia, Edward R T Tiekink

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IUCrData, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sofia Dallasta PedrosoLaboratório de Cristalografia, Esterodinâmica e Modelagem Molecular, Departamento de Química, Universidade Federal de São Carlos, 13565-905 São Carlos, SP, Brazil.
Ignez CaracelliDepartmento de Física, Universidade Federal de São Carlos, 13565-905 São Carlos, SP, Brazil.ORCID https://orcid.org/0000-0003-4945-7485
Julio Zukerman-SchpectorLaboratório de Cristalografia, Esterodinâmica e Modelagem Molecular, Departamento de Química, Universidade Federal de São Carlos, 13565-905 São Carlos, SP, Brazil.ORCID https://orcid.org/0000-0003-2191-4074
Monica Soto-MonsalveInstituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP, Brazil.
Regina H De Almeida SantosInstituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP, Brazil.
Carlos Roque D CorreiaInstituto de Química, Universidade Estadual de Campinas, UNICAMP, CP 6154, CEP 13084-917 Campinas, Brazil.ORCID https://orcid.org/0000-0001-5564-6675
Ariel L Llanes GarciaInstituto de Química, Universidade Estadual de Campinas, UNICAMP, CP 6154, CEP 13084-917 Campinas, Brazil.
Edward R T TiekinkResearch Centre for Crystalline Materials, School of Science and Technology, Sunway University, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia.ORCID https://orcid.org/0000-0003-1401-1520

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The title pyrrolidine compound, C

Indexed as

crystal structurepyrrolidine

Identifiers

PMID36339024
PMCPMC9462159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.